Explore All Access
Check if your research matches the topics covered in Cancer Biotherapy and Radiopharmaceuticals?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancer Biotherapy and Radiopharmaceuticals : Impact Factor & More
eISSN: 1557-8852pISSN: 1084-9785
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cancer Biotherapy and Radiopharmaceuticals Key Metrics
CiteScore 
5.2
H-Index
66
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.71
Topics Covered on Cancer Biotherapy and Radiopharmaceuticals
Lung cancer
Assay
Breast cancer
Overall survival
Western blot
Hepatocellular carcinoma
Doxorubicin
Radioguided Surgery
Radionuclide
Gene expression
Cell cycle
Hemoglobin
Clinical significance
Neuroendocrine tumors
Albumin
Colorectal cancer
Head and neck
Osteosarcoma
Immunohistochemistry
Progression-free survival
Cancer Biotherapy and Radiopharmaceuticals Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cancer Biotherapy and Radiopharmaceuticals ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Biotherapy and Radiopharmaceuticals
Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer Therapy.
- 29 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
METTL3 and HERC4: Elevated Expression and Impact on Hepatocellular Carcinoma Progression.
- 29 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Collagen Hydrogel Loaded With 9-cisRA-Lip Is an Option for Treatment of Secondary Lymphedema after Surgery.
- 29 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Intratumoral Distribution of [177Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer.
- 27 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Raddeanin A Inhibits Colorectal Cancer Growth and Ameliorates Oxaliplatin Resistance Through the WNT/β-Catenin Signaling Pathway.
- 25 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Efficacy Analysis of Bronchial Arterial Chemoembolization for Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- 11 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer Therapy.
- 29 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
METTL3 and HERC4: Elevated Expression and Impact on Hepatocellular Carcinoma Progression.
- 29 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Collagen Hydrogel Loaded With 9-cisRA-Lip Is an Option for Treatment of Secondary Lymphedema after Surgery.
- 29 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Intratumoral Distribution of [177Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer.
- 27 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Raddeanin A Inhibits Colorectal Cancer Growth and Ameliorates Oxaliplatin Resistance Through the WNT/β-Catenin Signaling Pathway.
- 25 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Efficacy Analysis of Bronchial Arterial Chemoembolization for Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.
- 11 Nov 2024
- Cancer biotherapy & radiopharmaceuticals
Compare Similar Journals with Cancer Biotherapy and Radiopharmaceuticals
Select Journals to Compare with Cancer Biotherapy and Radiopharmaceuticals
Total journals - 10
You can select up to 3 Journals at a time
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
OncoTargets and Therapy
Publisher: DOVE MEDICAL PRESS LTD
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Oncotarget
Publisher: Impact Journals
Cancer Cell International
Publisher: BMC
Oncology Reports
Publisher: SPANDIDOS PUBL LTD
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancers
Publisher: MDPI
BMC Cancer
Publisher: BMC
0 Journals Selected to compare with
Cancer Biotherapy and Radiopharmaceuticals
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancer Biotherapy and Radiopharmaceuticals
How long has Cancer Biotherapy and Radiopharmaceuticals been actively publishing? 
Cancer Biotherapy and Radiopharmaceuticals has been in operation since 1996 till date.
What is the publishing frequency of Cancer Biotherapy and Radiopharmaceuticals?
Cancer Biotherapy and Radiopharmaceuticals published with a Monthly frequency.
How many articles did Cancer Biotherapy and Radiopharmaceuticals publish last year?
In 2023, Cancer Biotherapy and Radiopharmaceuticals publsihed 35 articles.
What is the eISSN & pISSN for Cancer Biotherapy and Radiopharmaceuticals?
For Cancer Biotherapy and Radiopharmaceuticals, eISSN is 1557-8852 and pISSN is 1084-9785.
What is Citescore for Cancer Biotherapy and Radiopharmaceuticals?
Citescore for Cancer Biotherapy and Radiopharmaceuticals is 5.2.
What is the H Index for Cancer Biotherapy and Radiopharmaceuticals ?
H Index for Cancer Biotherapy and Radiopharmaceuticals is 66.
What is SNIP score for Cancer Biotherapy and Radiopharmaceuticals?
SNIP score for Cancer Biotherapy and Radiopharmaceuticals is 0.71.
What is the SJR for Cancer Biotherapy and Radiopharmaceuticals?
SJR for Cancer Biotherapy and Radiopharmaceuticals is Q2.
Who is the publisher of Cancer Biotherapy and Radiopharmaceuticals?
MARY ANN LIEBERT, INC is the publisher of Cancer Biotherapy and Radiopharmaceuticals.
